A groundbreaking shift in Canadian drug policy has taken place, as the regulators announce the use of psilocybin fungi for therapeutic applications. Until now, these substances were severely restricted, but a increasing body of research suggests they could offer aid for psychological conditions like PTSD. This development represents a substantial s